Karen C. Wolff

1.6k citations

20 papers · 1.0k indexed · h-index 12

Co-authors: Kelli Kuhen Jeremy S. Caldwell Hong Yin Yun He Badry BursulayaTao JiangCharles E. Samuel Glenn R. Hicks
Topics: HIV Research and Treatment (7 papers)HIV/AIDS drug development and treatment (7 papers)Pneumocystis jirovecii pneumonia detection and treatment (5 papers)
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Journal of the American Chemical Society PLANT PHYSIOLOGY Journal of Virology
Partner nations: United States Germany Colombia

In The Last Decade

Karen C. Wolff

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Karen C. Wolff

Since Specialization

Citations

This map shows the geographic impact of Karen C. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen C. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen C. Wolff more than expected).

Fields of papers citing papers by Karen C. Wolff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen C. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen C. Wolff. The network helps show where Karen C. Wolff may publish in the future.

Co-authorship network of co-authors of Karen C. Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of Karen C. Wolff. A scholar is included among the top collaborators of Karen C. Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen C. Wolff. Karen C. Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas 2025 ·Viruses ·Ulrich Betz,Robert Garces,Norbert Beier,S. Lindemann,Karen C. Wolff,Laura Riva,Melanie G. Kirkpatrick,(unknown),Case W. McNamara,Robert Damoiseaux,Brigitte N. Gomperts,Vaithilingaraja Arumugaswami,(unknown),Yong-Dae Gwon,Mikael Elofsson,Magnus Evander	1
2	Covalent Probes Reveal Small-Molecule Binding Pockets in Structured RNA and Enable Bioactive Compound Design 2025 ·Journal of the American Chemical Society ·(unknown),Jielei Wang,(unknown),(unknown),(unknown),Karen C. Wolff,(unknown),Xueyi Yang,Samantha M. Meyer,Sabine Ottilie,(unknown),(unknown),Case W. McNamara,Gurudutt Dubey,Arnab K. Chatterjee,Sumit K. Chanda,José Gallego,Jessica L. Childs‐Disney,Matthew D. Disney	0
3	Discovery and Optimization of a Novel Series of Influenza A Virus Replication Inhibitors Targeting the Nucleoprotein Protein–Protein Interaction 2025 ·Journal of Medicinal Chemistry ·Benjamin R. Taft,Matthew J. Hesse,Mulugeta Mamo,Dirksen E. Bussiere,Richard S.P. Huang,Patrick S. Lee,(unknown),Ellena Growcott,Karen C. Wolff,Kelli Kuhen,Johanna R. Abend,Kelly A. Wong,Don Ganem,Vincent H. J. Léonard,David C. Tully	1
4	Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency 2024 ·Bioorganic & Medicinal Chemistry Letters ·C. Rouch,Arnab K. Chatterjee,(unknown),(unknown),Alan Chu,(unknown),(unknown),Laura Riva,Case W. McNamara,Karen C. Wolff,(unknown),Anna De Falco,G.T. Montelione,(unknown)	0
5	Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 2019 ·Virology ·Christopher S. McAllister,(unknown),Ellena Growcott,Zhong Yang,(unknown),Karen C. Wolff,Zhong Chen,Olga Tanaseichuk,G. Lelais,S. Whitney Barnes,Glenn C. Federe,(unknown),John R. Walker,Yingyao Zhou,Kelli Kuhen	10
6	RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment 2009 ·Virology ·Zhiqun Li,Karen C. Wolff,Charles E. Samuel	70
7	Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening 2007 ·Virology ·Deborah G. Nguyen,Hong Yin,Yingyao Zhou,Karen C. Wolff,Kelli Kuhen,Jeremy S. Caldwell	29
8	Chemical Genetic Identification of Glutamine Phosphoribosylpyrophosphate Amidotransferase as the Target for a Novel Bleaching Herbicide in Arabidopsis 2007 ·PLANT PHYSIOLOGY ·Terence A. Walsh,(unknown),(unknown),(unknown),Paul R. Schmitzer,Glenn R. Hicks,Mary Honma,Wendy Matsumura,Karen C. Wolff,John P. Davies	26
9	Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·David Ellis,Kelli Kuhen,(unknown),Baogen Wu,Karen C. Wolff,Hong Yin,Badry Bursulaya,Jeremy S. Caldwell,Donald S. Karanewsky,Yun He	77
10	Mutations in an Auxin Receptor Homolog AFB5 and in SGT1b Confer Resistance to Synthetic Picolinate Auxins and Not to 2,4-Dichlorophenoxyacetic Acid or Indole-3-Acetic Acid in Arabidopsis 2006 ·PLANT PHYSIOLOGY ·Terence A. Walsh,(unknown),(unknown),Mary Honma,Glenn R. Hicks,Karen C. Wolff,Wendy Matsumura,John P. Davies	183
11	Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1 2006 ·Bioorganic & Medicinal Chemistry Letters ·Baogen Wu,Kelli Kuhen,(unknown),David Ellis,(unknown),(unknown),(unknown),Donald S. Karanewsky,(unknown),Karen C. Wolff,(unknown),Jeremy S. Caldwell,Yun He	17
12	Just-in-Time Purification: An Effective Solution for Cherry-Picking and Purifying Active Compounds from Large Legacy Libraries 2006 ·SLAS DISCOVERY ·(unknown),(unknown),(unknown),Tracy A. Spalding,Karen C. Wolff,Hong Yin,Kelli Kuhen,(unknown),(unknown),(unknown),Yingyao Zhou,John Isbell	3
13	Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I 2006 ·Bioorganic & Medicinal Chemistry Letters ·Tao Jiang,Kelli Kuhen,Karen C. Wolff,Hong Yin,(unknown),Jeremy S. Caldwell,Badry Bursulaya,(unknown),Yun He	265
14	Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2 2006 ·Bioorganic & Medicinal Chemistry Letters ·Tao Jiang,Kelli Kuhen,Karen C. Wolff,Hong Yin,(unknown),Jeremy S. Caldwell,Badry Bursulaya,Tove Tuntland,(unknown),Donald S. Karanewsky,Yun He	177
15	Design, Synthesis and Biological Evaluations of Novel Oxindoles as HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors. Part 1. 2006 ·ChemInform ·Tao Jiang,Kelli Kuhen,Karen C. Wolff,Hong Yin,(unknown),Jeremy S. Caldwell,Badry Bursulaya,(unknown),Yun He	5
16	Homogeneous High-Throughput Screening Assays for HIV-1 Integrase 3'-Processing and Strand Transfer Activities 2005 ·SLAS DISCOVERY ·Yu Wang,Heath E. Klock,(unknown),Karen C. Wolff,(unknown),(unknown),Jason Matzen,(unknown),Joanna Hale,Scott A. Lesley,Kelli Kuhen,Jeremy S. Caldwell,Achim Brinker	28
17	“UnPAKing” Human Immunodeficiency Virus (HIV) Replication: Using Small Interfering RNA Screening To Identify Novel Cofactors and Elucidate the Role of Group I PAKs in HIV Infection 2005 ·Journal of Virology ·Deborah G. Nguyen,Karen C. Wolff,Hong Yin,Jeremy S. Caldwell,Kelli Kuhen	56
18	Vaccinia Virus E3L Interferon Resistance Protein Inhibits the Interferon-Induced Adenosine Deaminase A-to-I Editing Activity 2001 ·Virology ·Yong Liu,Karen C. Wolff,(unknown),Charles E. Samuel	56
19	Corrosion monitoring with speckle correlation 1999 ·Applied Optics ·Thomas Fricke-Begemann,Gerd Gülker,Klaus D. Hinsch,Karen C. Wolff	34
20	Psychiatric Disability: Clinical, Legal, and Administrative Dimensions 1989 ·American Journal of Occupational Therapy ·Karen C. Wolff	2

About Karen C. Wolff

Karen C. Wolff is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Virology (109 citations), Organic Chemistry (489 citations) and Infectious Diseases (106 citations). Karen C. Wolff has collaborated with scholars based in United States, Germany and Colombia. Frequent co-authors include Kelli Kuhen, Jeremy S. Caldwell, Hong Yin, Yun He, Badry Bursulaya, Tao Jiang, Charles E. Samuel, Glenn R. Hicks, John P. Davies and Terence A. Walsh. Their work appears in journals such as Journal of the American Chemical Society, PLANT PHYSIOLOGY and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact